Sponsored By
Immupharma (IMM) RNS Announcements
Add to Alert list| Date | Time | Source | Announcement |
|---|---|---|---|
| 02 Oct 2006 | 07:00 AM | FDA Meeting on Lupus | |
| 26 Sep 2006 | 07:00 AM | Interim Results | |
| 01 Aug 2006 | 07:00 AM | Preliminary Results | |
| 05 Jul 2006 | 07:00 AM | Start of phase II trial | |
| 12 Jun 2006 | 05:04 PM | Accounting reference dates | |
| 10 May 2006 | 07:00 AM | Phase 1 Lupus results | |
| 11 Apr 2006 | 07:00 AM | Research Grants | |
| 07 Oct 2004 | 04:00 PM | Resignation of NOMAD | |
| 30 Jun 2004 | 10:48 AM | Final Results | |
| 19 Mar 2004 | 01:30 PM | Interim Results | |
| 18 Sep 2003 | 07:00 AM | Temporary Suspension | |
| 31 Jul 2003 | 01:06 PM | Result of AGM | |
| 27 Jun 2003 | 07:00 AM | Final Results | |
| 28 Mar 2003 | 12:24 PM | Issue of Convertible Loan | |
| 01 Nov 2002 | 04:08 PM | Director Shareholding | |
| 30 Sep 2002 | 03:52 PM | Interim Results | |
| 26 Jul 2002 | 12:57 PM | Result of AGM | |
| 03 Jul 2002 | 03:37 PM | Director Shareholding | |
| 01 Jul 2002 | 07:00 AM | Preliminary Results | |
| 01 Oct 2001 | 02:35 PM | Dir Shareholding - amendment | |
| 01 Oct 2001 | 02:04 PM | Director Shareholding | |
| 28 Sep 2001 | 07:01 AM | Interim Results | |
| 15 Aug 2001 | 05:27 PM | Corporate Action | |
| 14 Aug 2001 | 06:13 PM | Corporate Action - Update | |
| 13 Aug 2001 | 05:57 PM | Corporate Action-Replacement | |
| 13 Aug 2001 | 07:51 AM | Corporate Action | |
| 07 Aug 2001 | 11:15 AM | Result of AGM & EGM | |
| 07 Aug 2001 | 09:35 AM | Fthr re Placing & Open Offer | |
| 17 Jul 2001 | 04:04 PM | Corporate Action | |
| 13 Jul 2001 | 02:59 PM | Fthr re Placing & Open Offer | |
| 13 Jul 2001 | 10:40 AM | Placing & Open Offer-Replace | |
| 13 Jul 2001 | 07:07 AM | Corporate Action | |
| 13 Jul 2001 | 07:00 AM | Proposed Placing & Open Offer | |
| 13 Jul 2001 | 07:00 AM | Preliminary Results | |
| 29 Jun 2001 | 04:43 PM | Statement re Suspension | |
| 20 Jun 2001 | 07:00 AM | Additional Funding | |
| 25 Apr 2001 | 10:31 AM | Additional Funding | |
| 27 Mar 2001 | 07:00 AM | Funding to Support Expansion | |
| 31 Oct 2000 | 07:00 AM | Second Interim Results 2000 | |
| 12 Jul 2000 | 02:24 PM | Interim Statement | |
| 19 Apr 2000 | 05:10 PM | Result of Open Offer | |
| 18 Apr 2000 | 05:48 PM | Result of EGM | |
| 18 Apr 2000 | 11:05 AM | Result of EGM | |
| 27 Mar 2000 | 07:01 AM | Restoration of Trading on AIM | |
| 24 Mar 2000 | 04:26 PM | Statement re Restoration of Dealing | |
| 24 Mar 2000 | 08:47 AM | Entitlement Details | |
| 24 Mar 2000 | 08:46 AM | Proposed Acquisition and Placing and Open Offer | |
| 17 Feb 2000 | 01:56 PM | Statement re Suspension of Trading | |
| 18 Jan 2000 | 03:55 PM | Statement re Share Price Movement | |
| 26 Nov 1999 | 02:31 PM | Insinger Townsley Appointed as Nominated Broker |
ImmuPharma is a pharma company headquartered in London with its research R&D team, ImmuPharma Biotech, based in France.
ImmuPharma listed on AIM under the ticker IMM.
IMM research strategy is based on two strategic axes: research based on external collaboration aimed at discovering new active ingredients, which has led to the development of our most advanced project in terms of clinical development: P140 an active peptide against the auto-immune disease, Lupus SLE and internal research based on the use of molecular programming technologies, which has notably led to the development of the BioAMB and BioCIN projects.
IMM share price listed in London at 1,190p in 2000.
Latest directors dealings
- 2 days ago Compass Group
- 2 days ago Rathbones Group
- 2 days ago Sage Group
- 2 days ago NATWEST GROUP
- 2 days ago Kier Group